Lechleider Robert

Chief Medical OfficerImmunome Inc. (IMNM) · full profile →Form 4 · filed Jul 7, 2026
Net Selling
Open-Market Buys
$0
Open-Market Sells
$1.2M
Net Open-Market Flow
-$1.2M
Transactions
5
4 non-derivative · 1 derivative

Non-Derivative Transactions (Table I)

DateActionSharesPriceValueOwned After
Jul 2, 2026Option exercise(M)55K$8.73$480K71K
Jul 2, 2026Sell(S)23K$21.95$499K48K
Jul 2, 2026Sell(S)16K$22.76$369K32K
Jul 2, 2026Sell(S)16K$23.44$377K16K

Derivative Transactions (Table II)

DateActionSharesPriceValueOwned After
Jul 2, 2026Option exercise(M)55K$0290K

Transaction Codes

M
Option exercise / conversion
S
Open-market sale

Data Source & Provenance

Parsed from a single SEC EDGAR Form 4 filing (accession 0001997584-26-000004) within minutes of acceptance. Every field above traces to the original document. Verify it directly: